| scholarly article | Q13442814 |
| P2093 | author name string | D. G. Payne | |
| W. J. Simpson | |||
| M. E. Platts | |||
| C. Keen | |||
| P2860 | cites work | Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation | Q66890039 |
| A new method of determining the fraction of hypoxic cells in a transplantable murine sarcoma | Q67561355 | ||
| Multiple daily fractions in radiotherapy | Q70822110 | ||
| Cancer clinical trials | Q27710207 | ||
| Journal of the Canadian Association of Radiologists | Q27711416 | ||
| Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 | ||
| Cumulative radiation effect. Part VI: simple nomographic and tabular methods for the solution of practical problems. | Q50722454 | ||
| Minimization: A new method of assigning patients to treatment and control groups | Q52909206 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| astrocytoma | Q177755 | ||
| adaptive radiation therapy | Q180507 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 2301-2306 | |
| P577 | publication date | 1982-12-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial | |
| P478 | volume | 50 |
| Q48926304 | Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors |
| Q70686642 | Acute reactions in rat feet exposed to multiple fractions of X-rays per day |
| Q36468064 | Back to the future--radiotherapy in high grade gliomas |
| Q38100648 | Chemotherapy for malignant gliomas of the brain: a review of ten-years experience |
| Q55484162 | Cisplatin and etoposide combination therapy for primary glial tumors: Preliminary results |
| Q48421519 | Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas |
| Q44730621 | Development of an inductive, non-invasive RF applicator for studying hyperthermia in a rat brain tumour model |
| Q43415134 | Dielectric properties of human glioma and surrounding tissue |
| Q26470382 | External beam radiation dose escalation for high grade glioma |
| Q41524743 | Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases) |
| Q55478814 | Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. |
| Q41482096 | Hyperfractionation: where do we stand? |
| Q36081097 | Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma |
| Q55483852 | In vitro intrinsic radiation sensitivity of glioblastoma multiforme |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q36836242 | Malignant gliomas in children |
| Q37476857 | Management of newly diagnosed glioblastoma: guidelines development, value and application |
| Q48632169 | Misonidazole combined with hyperfractionation in the management of malignant glioma |
| Q36078900 | Modified optimal fractionation for poor prognosis malignant gliomas: an elusive search |
| Q36745997 | Multiple fraction-per-day radiotherapy for patients with brain stem tumors |
| Q55483325 | Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas |
| Q36796882 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy |
| Q35385779 | Optimizing glioblastoma resection: intraoperative mapping and beyond |
| Q37159513 | Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients |
| Q55484778 | Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. |
| Q60339288 | Photodynamic Therapy of Malignant Brain Tumours |
| Q48187719 | Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain |
| Q48368990 | Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas |
| Q34132950 | Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy. |
| Q48961365 | Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults |
| Q48240589 | Radiation treatment with twice a day fractionation versus conventional fractionation in high grade astrocytoma. A retrospective study |
| Q26752579 | Radioresistance of Brain Tumors |
| Q33184436 | Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review |
| Q36882380 | Radiotherapy of glioblastoma |
| Q37196375 | Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? |
| Q48404651 | Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma |
| Q43742085 | Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas |
| Q55487065 | Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. |
| Q30605562 | Target volumes in radiotherapy for high-grade malignant glioma of the brain. |
| Q40560864 | The basis for current treatment recommendations for malignant gliomas |
| Q39244859 | The fallacy of the localized supratentorial malignant glioma |
| Q60547818 | The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options |
| Q90583610 | Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis |
| Q33708309 | Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma |
| Q48488949 | Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice? |
Search more.